Psychopharmacology, 219(4), 10991109
doi: 10.3389/fendo.2019.00389 Received 07 April 2019 Accepted 30 May 2019 Published 19 June 2019 Volume 10 - 2019 Edited by Jens Juul Holst, University of Copenhagen, Denmark Reviewed by Leon Bach, Monash University, Australia
The FDA does not evaluate compounded drug products for safety, effectiveness, or quality. The ad did not include verbal recognition of the fact its drugs are compounded or not FDA approved
12 Furthermore, the act of strength training itself can independently contribute to improvements in blood pressure, cholesterol levels, and cardiovascular health
16 While GLP-1s hold promise, the evidence is not yet strong enough to call them an Alzheimers treatment or proven prevention tool
It is effective and safe to use